Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.

C. Schmidt, H. Bai, Z. Lin, A. Risitano, P. Barlow, D. Ricklin, and J. Lambris. Journal of Immunology, 190 (11): 5712--5721 (June 2013)
DOI: 10.4049/jimmunol.1203548

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Antonio Dell'Aquila

Antonio Wünsch

Antonio Accardi

Antonio Bergua

Antonio Pinto

Other publications of authors with the same name

Peptide inhibitors of C3 activation as a novel strategy of complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria.A. Risitano, D. Ricklin, Y. Huang, E. Reis, H. Chen, P. Ricci, Z. Lin, C. Pascariello, M. Raia, M. Sica and 7 other author(s). 123 (13): 2094--2101 (March 2014)Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.C. Schmidt, H. Bai, Z. Lin, A. Risitano, P. Barlow, D. Ricklin, and J. Lambris. Journal of Immunology, 190 (11): 5712--5721 (June 2013)Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia.M. Lindorfer, E. Cook, E. Reis, D. Ricklin, A. Risitano, J. Lambris, and R. Taylor. Clinical immunology (Orlando, Fla.), (October 2016)Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside interventionD. Mastellos, D. Yancopoulou, P. Kokkinos, M. Huber-Lang, G. Hajishengallis, A. Biglarnia, F. Lupu, B. Nilsson, A. Risitano, D. Ricklin and 1 other author(s). European Journal of Clinical Investigation, 45 (4): 423--440 (March 2015)Applying complement therapeutics to rare diseases.E. Reis, D. Mastellos, D. Yancopoulou, A. Risitano, D. Ricklin, and J. Lambris. Clinical immunology (Orlando, Fla.), 161 (2): 225--240 (December 2015)Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria.Z. Lin, C. Schmidt, S. Koutsogiannaki, P. Ricci, A. Risitano, J. Lambris, and D. Ricklin. 126 (7): 891--894 (August 2015)

BibSonomy

Disambiguation of "Risitano, Antonio M"

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.

Please choose a person to relate this publication to

Antonio Dell'Aquila

Antonio Wünsch

Antonio Accardi

Antonio Bergua

Antonio Pinto

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Risitano, Antonio M"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.

Please choose a person to relate this publication to

Antonio Dell'Aquila

Antonio Wünsch

Antonio Accardi

Antonio Bergua

Antonio Pinto

Other publications of authors with the same name

Disambiguation

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.